MedTrace Logo

HDL-Atherosclerosis Treatment Study (HATS)

NCT00000553 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2016-02-10

No results posted yet for this study

Summary

To measure the effects of lipid-lowering drugs and/or antioxidant vitamins on progression or regression of coronary heart disease as measured by quantitative angiography in patients with low high density lipoprotein (HDL) cholesterol.

Conditions

Interventions

DRUG

simvastatin

DRUG

niacin

DRUG

antioxidants

Sponsors & Collaborators

Principal Investigators

  • Bruce Brown · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Model
FACTORIAL

Eligibility

Min Age
35 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1994-09-30
Completion
2001-02-28

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000553 on ClinicalTrials.gov